GSA Capital Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-81,736
Closed -$5.75M 2087
2015
Q3
$5.75M Buy
81,736
+71,374
+689% +$5.87M 0.28% 31
2015
Q2
$935K Sell
10,362
-9,507
-48% -$917K 0.04% 958
2015
Q1
$2M Buy
19,869
+14,711
+285% +$1.48M 0.08% 348
2014
Q4
$519K Buy
5,158
+546
+12% +$54.4K 0.04% 907
2014
Q3
$444K Sell
4,612
-1,979
-30% -$188K 0.02% 1010
2014
Q2
$614K Buy
+6,591
New +$576K 0.03% 1001
2014
Q1
Sell
-6,153
Closed -$515K 1938
2013
Q4
$515K Sell
6,153
-7,853
-56% -$639K 0.04% 825
2013
Q3
$1.04M Buy
14,006
+11,359
+429% +$852K 0.08% 331
2013
Q2
$210K Buy
+2,647
New +$212K 0.02% 1063

Other funds holding MJN

GSA Capital Partners's MJN Position: Q4 2015 in Review

GSA Capital Partners sold out of Mead Johnson Nutrition Company (MJN) in Q4 2015, closing a stake of 81,736 shares — an estimated $5.75M sold.

GSA Capital Partners first reported a position in MJN in Q2 2013 and held it in 9 quarters. The position peaked at $5.75M in Q3 2015. 549 funds tracked by Wall St. Rank hold MJN as of Q4 2015.

  • GSA Capital Partners reported no remaining Mead Johnson Nutrition Company position as of Q4 2015 after selling out during the quarter.
  • GSA Capital Partners sold 81,736 Mead Johnson Nutrition Company shares in Q4 2015, an estimated $5.75M.
  • GSA Capital Partners first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 9 quarters.
  • GSA Capital Partners's Mead Johnson Nutrition Company position peaked at $5.75M in Q3 2015.
  • 549 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2015.

Based on GSA Capital Partners's 13F filing for Q4 2015, filed 9 Feb 2016.